Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Clinical trial NCT00527657 · COMPLETED

Trial details

NCT number: NCT00527657
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Neoplasms Melanoma

Start date: 2006-02-09
Primary completion: 2012-02-02
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.